In addition, ER stress inhibitors improve leptin sensitivity and attenuate obesity by suppressing hypothalamic IKKβ/NF-κB and increasing STAT-JAK as a leptin sensitizers in mice (18–20). Here, NFKB1 is linked to obesity disorder.